Overview

Studying Different Formulations of SR13668 in Healthy Volunteers

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
This randomized early phase I trial is studying different formulations of SR13668 in healthy volunteers. Giving SR13668 may help doctors learn more about how SR13668 is used by the body. It is not yet known which formulation of SR13668 is most effectively used by the body.
Phase:
Phase 1
Details
Lead Sponsor:
National Cancer Institute (NCI)